Mobile

A Study of the Effectiveness and Safety of Ustekinumab (STELARA®) and CNTO 1959 Administered Under the Skin of Patients with Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy Kl...

Mise à jour : Il y a 5 ans
Référence : EUCTR2011-001122-18

A Study of the Effectiveness and Safety of Ustekinumab (STELARA®) and CNTO 1959 Administered Under the Skin of Patients with Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy Klinické hodnocení účinnosti a bezpečnosti ustekinumabu (STELARA®) a CNTO 1959 podávaných podkožně pacientům s aktivní revmatoidní artritidou při souběžné léčbě methotrexátem

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to evaluate the efficacy of ustekinumab and CNTO 1959 in reducing the signs and symptoms of disease in subjects with active rheumatoid arthritis (RA) despite concomitant methotrexate (MTX) therapy and to evaluate the safety of ustekinumab and CNTO 1959 in this population.

Critère d'inclusion

  • Rheumatoid Arthritis

Liens